A randomised multi-centre open-label phase 3 study of the Bruton's tyrosine kinase inhibitor PCI-32765 versus chlorambucil in patients 65 years or older with treatment-naive chronic lymphocytic leukem

Project: Research

StatusFinished
Effective start/end date16/01/1328/02/14